Last reviewed · How we verify
NCT02594956: IPOD
Impact of the Absence of Nasogastric Decompression After Pancreaticoduodenectomy
NA trial testing no nasogastric tube in Digestive System Surgical Procedure in 125 participants. Completed in 5 December 2018.
10 September 2018
Quick facts
| Lead sponsor | Rennes University Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 125 |
| Start date | 16 December 2015 |
| Primary completion | 10 September 2018 |
| Estimated completion | 5 December 2018 |
| Sites | 1 location across France |
Drugs / interventions tested
- no nasogastric tube
- nasogastric tube
Conditions studied
- Digestive System Surgical Procedure — all drugs for Digestive System Surgical Procedure →
- Pancreaticoduodenectomy — all drugs for Pancreaticoduodenectomy →
Sponsor
Rennes University Hospital
Who can join
Adults 18 to 75, any sex, with Digestive System Surgical Procedure or Pancreaticoduodenectomy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The use of nasogastric (NG) decompression after pancreaticoduodenectomy (PD) is a current practice. NG tube is associated with a high rate of morbidity including pulmonary morbidity, delayed gastric emptying and finally an increased length of hospital stay. The absence of NG decompression could be the corner stone of the concept of the enhanced recovery program after PD.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Nasogastric Decompression vs No Decompression After Pancreaticoduodenectomy: The Randomized Clinical IPOD Trial.
Bergeat D, Merdrignac A, Robin F, Gaignard E, et al · · 2020 · cited 18× · PMID 32667635 · DOI 10.1001/jamasurg.2020.2291
Verify or expand the search:
- PubMed search for NCT02594956
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Rennes University Hospital trials
Trials by the same sponsor.
- NCT07527949 — PASTRAMI : Patient-specific Statistics for Microstructure-augmented Connectomics · NA · not yet recruiting
- NCT07449832 — Sperm Epigenome in Hodgkin Lymphoma · NA · not yet recruiting
- NCT06950398 — Normothermic Oxygenated Perfusion (NMP) Viability Testing Before Transplantation of Discarded Livers · Phase 2 · not yet recruiting
- NCT07188753 — Randomized Controlled Trial Testing the Efficacy of Transcranial Magnetic Stimulation by Accelerated & High-dose Theta-b · NA · not yet recruiting
- NCT06898099 — Evaluation of the Efficacy of E2R Hypnotherapy in the Management of Chronic Insomnia in Primary Care (HypERR) · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02594956 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Rennes University Hospital
- Last refreshed: 15 February 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02594956.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing